Summary
Several clinical trials have shown that the duration of treatment of painful vertebral syndromes can be shortened by using a combination of vitamins B1, B6, B12 and diclofenac instead of diclofenac. In addition, a more efficient pain relief could be achieved by the combination therapy.
In order to confirm these results, we compared the clinical efficacy of diclofenac (25 mg) and a combination preparation with diclofenac (25 mg) plus vitamins B1 (thiamine nitrate 50 mg), B6 (pyridoxine hydrochloride 50 mg) and B12 (cyanocobalamin 0.25 mg) in a multicentric randomized double-blind study including 418 patients. All patients received 3×2 capsules daily for a maximum of 2 weeks. In case of total pain relief, therapy should be discontinued after one week.
Data of 376 patients could be evaluated. 53 out of 184 patients receiving the combination and 48 out of 192 patients treated with diclofenac alone could stop therapy due to sufficient pain relief after one week.
The evaluation of the “Hoppe Pain Questionnaire” and the data concerning pain intensity also revealed better results for the combination preparation. The differences in favour of the B-vitamin-diclofenac-combination were statistically significant in patients with severe pain at the beginning of therapy.
Considering undesirable side-effects (symptoms in 70 out of 418 patients) there were no significant differences between the two medications.
This clinical trial provides further evidence that the combination therapy with diclofenac plus B-vitamins is more effective than diclofenac alone for the treatment of painful vertebral syndroms.
Literatur
Hoppe F (1985) Zur Faktorenstruktur von Schmerzerleben und Schmerzverhalten bei chronischen Schmerzpatienten. Diagnostica 31:70–78
Kuhlwein A, Meyer HJ, Koehler CO (1990) Einsparung von Diclofenac durch B-Vitamine: Ergebnisse einer randomisierten Doppelblindprüfung mit reduzierten Tagesdosierungen von Diclofenac (75 mg Diclofenac versus 75 mg Diclofenac plus B-Vitamine) bei akuten Lendenwirbelsäulensyndromen. Klin Wochenschr 68:107–115
Lettko M, Schwieger G, Pudel V (1986) Ergebnisse einer Doppelblindstudie, Neurofenac gegen Diclofenac, zum Nachweis der additiven Wirksamkeit der B-Vitamine. Rheuma, Schmerz & Entzündung 6(8):22–30
Vetter G, Brüggemann G, Lettko M et al. (1988) Verkürzung der Diclofenac-Therapie durch B-Vitamine. Ergebnisse einer randomisierten Doppelblindstudie, Diclofenac 50 mg gegen Diclofenac 50 mg plus B-Vitamine, bei schmerzhaften Wirbelsäulenerkrankungen mit degenerativen Veränderungen. Z Rheumatol 47:351–362
Zöllner N, Fassl H, Jurna I, Pietrzik K, Schattenkirchner M (1988) Klinische Bedeutung von Vitamin B1, B6, B12 in der Schmerztherapie. Ein Konsensusgespräch. Steinkopff, Darmstadt
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brüggemann, G., Koehler, C.O. & Koch, E.M.W. Ergebnisse einer Doppelblindprüfung Diclofenac+Vitamin B1, B6, B12 versus Diclofenac bei Patienten mit akuten Beschwerden im Lendenwirbelsäulenbereich. Klin Wochenschr 68, 116–120 (1990). https://doi.org/10.1007/BF01646858
Issue Date:
DOI: https://doi.org/10.1007/BF01646858